Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2014. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2013. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 21.4B USD
- Positions
- 65
- Share of the ten largest
- 42.6%
The ten largest positions Q4 2013
- Thermo Fisher Scientific 5.4%▼ −1.8%
- Twenty First Centy Fox Inc 4.9%▲ +22.7%
- Meta Platforms 4.7%▲ +312.7%
- Valeant Pharmaceuticals Intl 4.6%▼ −6.9%
- Capital One 4.5%▼ −19.4%
- Time Warner Inc 4.4%▼ −9.4%
- Lowe's 4.1%▲ +2.3%
- Valero Energy 3.7%▲ +92.8%
- Michael Kors HLDGS Ltd 3.2%▼ −11.2%
- Walgreen Co 3.1%new
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2013
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | 5.4% | 10,375,656 | 1.2B USD | −1.8% reduced | Q2 2013 or earlier 3 quarters |
| Valeant Pharmaceuticals Intl | 4.6% | 8,329,004 | 977.8M USD | −6.9% reduced | Q2 2013 or earlier 3 quarters |
| COF Capital One | 4.5% | 12,635,752 | 968.0M USD | −19.4% reduced | Q2 2013 or earlier 3 quarters |
| Time Warner Inc | 4.4% | 13,425,674 | 936.0M USD | −9.4% reduced | Q2 2013 or earlier 3 quarters |
| Michael Kors HLDGS Ltd | 3.2% | 8,342,605 | 677.3M USD | −11.2% reduced | Q2 2013 or earlier 3 quarters |
| LYB LyondellBasell | 3.0% | 7,970,748 | 639.9M USD | −14.4% reduced | Q2 2013 or earlier 3 quarters |
| MU Micron Technology | 2.9% | 28,160,135 | 612.5M USD | −24.6% reduced | Q2 2013 or earlier 3 quarters |
| MA Mastercard | 2.5% | 642,087 | 536.4M USD | −15.9% reduced | Q2 2013 or earlier 3 quarters |
| DHR Danaher Corporation | 2.2% | 6,159,351 | 475.5M USD | −46.1% reduced | Q2 2013 or earlier 3 quarters |
| Monsanto Co New | 1.9% | 3,464,037 | 403.7M USD | −22.3% reduced | Q2 2013 or earlier 3 quarters |
| Alexion Pharmaceuticals Inc | 1.8% | 2,877,008 | 382.3M USD | −16.7% reduced | Q2 2013 or earlier 3 quarters |
| Mcgraw Hill Finl Inc | 1.3% | 3,614,429 | 282.6M USD | −0.7% reduced | Q2 2013 or earlier 3 quarters |
| UHS Universal Health Services | 1.1% | 3,009,890 | 244.6M USD | −25.6% reduced | Q2 2013 or earlier 3 quarters |
| MET MetLife | 1.1% | 4,216,800 | 227.4M USD | −38.3% reduced | Q2 2013 or earlier 3 quarters |
| ADBE Adobe Inc. | 0.9% | 3,108,762 | 186.1M USD | −41.6% reduced | Q2 2013 or earlier 3 quarters |
| HUM Humana | 0.4% | 927,093 | 95.7M USD | −22.6% reduced | Q2 2013 or earlier 3 quarters |
| Eastman Chem Co | 0.2% | 495,510 | 40.0M USD | −91.4% reduced | Q2 2013 or earlier 3 quarters |
| BAC Bank of America | 2.5% | 34,392,936 | 535.5M USD | −23.4% reduced | Q3 2013 2 quarters |
| DIS Walt Disney Company (The) | 2.1% | 5,996,321 | 458.1M USD | −9.7% reduced | Q3 2013 2 quarters |
| BIDU Baidu (ADR) | 1.3% | 1,511,841 | 268.9M USD | −43.4% reduced | Q3 2013 2 quarters |
| HCA HCA Healthcare | 0.6% | 2,654,617 | 126.7M USD | −4.6% reduced | Q3 2013 2 quarters |
| Blackberry Ltd | 0.3% | 7,277,341 | 54.1M USD | −10.3% reduced | Q3 2013 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 14.5%
- Health Care 12.1%
- Communication Services 7.1%
- Technology 5.1%
- Consumer Discretionary 4.8%
- Energy 3.7%
- Consumer Staples 3.1%
- Materials 3.0%
- not in our coverage 46.7%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors